PHOENIX-Feasibility: picking up hidden osteoporosis effectively during normal CT imaging without additional x-rays

Not Applicable

• Conditions: Osteoporosis; Musculoskeletal Diseases

• Registration Number: ISRCTN14722819
• Lead Sponsor: Cambridge University NHS Foundation Trust

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35613783/ (added 27/05/2022)

Detailed Description

Not available

Study Timeline

• Study Start: 2019-08-15
• Last Update Posted: 12 August 2024
• Study Completion: 2024-12-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 625

Inclusion Criteria

1. Attend one of five participating radiology departments
2. Volunteers able to provide informed consent
3. Women aged =65 - 90 and men aged =75 – 90 years inclusive
4. Attending for CT, for any clinical reason, where the spine and/or hips are visible in the scan images

Exclusion Criteria

1. Aged > 90
2. Bilateral metalwork in hips
3. Unable to provide valid consent
4. Known to be receiving prescription treatment for osteoporosis other than calcium/vitamin D (i.e. bisphosphonate drug, strontium ranelate, denosumab, raloxifene or teriparatide)
5. Prone CT scan

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Recruitment rate recorded as the number of eligible participants who consent to participate in the study in 10 months <br>2. Attrition rate recorded as the number of participants who consent to participate that remain in the study until the end of follow up one year after recruitment

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures